Association of Vpu with hepatitis C virus NS3/4A stimulates transcription of type 1 human immunodeficiency virus

Virus Research

Volumn 163, Issue 1, 2012, Pages 74-81

  Kang, Lei ^a   Luo, Zhen ^a,b   Li, Youxing ^a,b   Zhang, Wenjing ^a,b   Sun, Wei ^a   Li, Wei ^a   Chen, Yanni ^a,b   Liu, Fang ^a,b   Xia, Xueshan ^c   Zhu, Ying ^a,b   Wu, Jianguo ^a,b  

^a WUHAN UNIVERSITY   (China)

^b Wuhan Institites of Biotechnology   (China)

^c KUNMING UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Co infection; HCV; HIV 1; NS3 4A; Vpu

Indexed keywords

NONSTRUCTURAL PROTEIN 3; NONSTRUCTURAL PROTEIN 4A; VPU PROTEIN;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME REGULATION; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MIXED INFECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SECRETION; PROTEIN STABILITY; UBIQUITINATION; VIRUS REPLICATION;

CARRIER PROTEINS; CELL LINE; HEPACIVIRUS; HEPATOCYTES; HIV-1; HUMAN IMMUNODEFICIENCY VIRUS PROTEINS; HUMANS; PROTEIN BINDING; TRANSCRIPTION, GENETIC; VIRAL NONSTRUCTURAL PROTEINS; VIRAL REGULATORY AND ACCESSORY PROTEINS; VIRULENCE FACTORS; VIRUS REPLICATION;

HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84855571580     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2011.08.011     Document Type: Article

References (56)

1. Ballana E., Senserrich J., Pauls E., Faner R., Mercader J.M., Uyttebroeck F., Palou E., Mena M.P., Grau E., Clotet B., Ruiz L., Telenti A., Ciuffi A., Este J.A. ZNRD1 (zinc ribbon domain-containing 1) is a host cellular factor that influences HIV-1 replication and disease progression. Clin. Infect. Dis. 2010, 50(7):1022-1032.
2. Beld M., Penning M., Lukashov V., McMorrow M., Roos M., Pakker N., van den Hoek A., Goudsmit J. Evidence that both HIV and HIV-induced immunodeficiency enhance HCV replication among HCV seroconverters. Virology 1998, 244(2):504-512.
3. Bour S., Perrin C., Akari H., Strebel K. The human immunodeficiency virus type 1 Vpu protein inhibits NF-kappa B activation by interfering with beta TrCP-mediated degradation of Ikappa B. J. Biol. Chem. 2001, 276(19):15920-15928.
4. Brass V., Berke J.M., Montserret R., Blum H.E., Penin F., Moradpour D. Structural determinants for membrane association and dynamic organization of the hepatitis C virus NS3-4A complex. Proc. Natl. Acad. Sci. U.S.A. 2008, 105(38):14545-14550.
5. Bruno R., Galastri S., Sacchi P., Cima S., Caligiuri A., Defranco R., Milani S., Gessani S., Fantuzzi L., Liotta F., Frosali F., Antonucci G., Pinzani M., Marra F. The HIV envelope protein GP120 modulates the biology of human hepatic stellate cells: a link between HIV infection and liver fibrogenesis. Gut 2009, 59(4):428-429.
6. Butticaz C., Michielin O., Wyniger J., Telenti A., Rothenberger S. Silencing of both beta-TrCP1 and HOS (beta-TrCP2) is required to suppress human immunodeficiency virus type 1 Vpu-mediated CD4 down-modulation. J. Virol. 2007, 81(3):1502-1505.
7. Cadwell K., Coscoy L. Ubiquitination on nonlysine residues by a viral E3 ubiquitin ligase. Science 2005, 309(5731):127-130.
8. Chen D., Ma H., Hong H., Koh S.S., Huang S.M., Schurter B.T., Aswad D.W., Stallcup M.R. Regulation of transcription by a protein methyltransferase. Science 1999, 284(5423):2174-2177.
9. Darnell G.A., Schroder W.A., Gardner J., Harrich D., Yu H., Medcalf R.L., Warrilow D., Antalis T.M., Sonza S., Suhrbier A. SerpinB2 is an inducible host factor involved in enhancing HIV-1 transcription and replication. J. Biol. Chem. 2006, 281(42):31348-31358.
10. Deng L., Nagano-Fujii M., Tanaka M., Nomura-Takigawa Y., Ikeda M., Kato N., Sada K., Hotta H. NS3 protein of Hepatitis C virus associates with the tumour suppressor p53 and inhibits its function in an NS3 sequence-dependent manner. J. Gen Virol. 2006, 87(Pt 6):1703-1713.
11. Douglas J.L., Viswanathan K., McCarroll M.N., Gustin J.K., Fruh K., Moses A.V. Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/Tetherin via a {beta}TrCP-dependent mechanism. J. Virol. 2009, 83(16):7931-7947.
12. Dumont S., Cheng W., Serebrov V., Beran R.K., Tinoco I., Pyle A.M., Bustamante C. RNA translocation and unwinding mechanism of HCV NS3 helicase and its coordination by ATP. Nature 2006, 439(7072):105-108.
13. Errington W., Wardell A.D., McDonald S., Goldin R.D., McGarvey M.J. Subcellular localisation of NS3 in HCV-infected hepatocytes. J. Med. Virol. 1999, 59(4):456-462.
14. Foy E., Li K., Sumpter R., Loo Y.M., Johnson C.L., Wang C., Fish P.M., Yoneyama M., Fujita T., Lemon S.M., Gale M. Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling. Proc. Natl. Acad. Sci. U.S.A. 2005, 102(8):2986-2991.
15. Foy E., Li K., Wang C., Sumpter R., Ikeda M., Lemon S.M., Gale M. Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science 2003, 300(5622):1145-1148.
16. Gomez-Gonzalo M., Carretero M., Rullas J., Lara-Pezzi E., Aramburu J., Berkhout B., Alcami J., Lopez-Cabrera M. The hepatitis B virus X protein induces HIV-1 replication and transcription in synergy with T-cell activation signals: functional roles of NF-kappaB/NF-AT and SP1-binding sites in the HIV-1 long terminal repeat promoter. J. Biol. Chem. 2001, 276(38):35435-35443.
17. Greub G., Ledergerber B., Battegay M., Grob P., Perrin L., Furrer H., Burgisser P., Erb P., Boggian K., Piffaretti J.C., Hirschel B., Janin P., Francioli P., Flepp M., Telenti A. Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. Lancet 2000, 356(9244):1800-1805.
18. Gualberto A., Baldwin A.S. p53 and Sp1 interact and cooperate in the tumor necrosis factor-induced transcriptional activation of the HIV-1 long terminal repeat. J. Biol. Chem. 1995, 270(34):19680-19683.
19. Hahm B., Han D.S., Back S.H., Song O.K., Cho M.J., Kim C.J., Shimotohno K., Jang S.K. NS3-4A of hepatitis C virus is a chymotrypsin-like protease. J. Virol. 1995, 69(4):2534-2539.
20. Hamid T., Kakar S.S. PTTG/securin activates expression of p53 and modulates its function. Mol. Cancer 2004, 3:18.
21. He J., Choe S., Walker R., Di Marzio P., Morgan D.O., Landau N.R. Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J. Virol. 1995, 69(11):6705-6711.
22. Hsu N.Y., Ilnytska O., Belov G., Santiana M., Chen Y.H., Takvorian P.M., Pau C., van der Schaar H., Kaushik-Basu N., Balla T., Cameron C.E., Ehrenfeld E., van Kuppeveld F.J., Altan-Bonnet N. Viral reorganization of the secretory pathway generates distinct organelles for RNA replication. Cell 2010, 141(5):799-811.
23. Ishido S., Fujita T., Hotta H. Complex formation of NS5B with NS3 and NS4A proteins of hepatitis C virus. Biochem. Biophys. Res. Commun. 1998, 244(1):35-40.
24. Iwai A., Hasumura Y., Nojima T., Takegami T. Hepatitis C virus nonstructural protein NS3 binds to Sm-D1, a small nuclear ribonucleoprotein associated with autoimmune disease. Microbiol. Immunol. 2003, 47(8):601-611.
25. Kim J.L., Morgenstern K.A., Lin C., Fox T., Dwyer M.D., Landro J.A., Chambers S.P., Markland W., Lepre C.A., O'Malley E.T., Harbeson S.L., Rice C.M., Murcko M.A., Caron P.R., Thomson J.A. Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide. Cell 1996, 87(2):343-355.
26. Klenerman P., Kim A. HCV-HIV coinfection: simple messages from a complex disease. PLoS Med. 2007, 4(10):e240.
27. Laskus T., Radkowski M., Piasek A., Nowicki M., Horban A., Cianciara J., Rakela J. Hepatitis C virus in lymphoid cells of patients coinfected with human immunodeficiency virus type 1: evidence of active replication in monocytes/macrophages and lymphocytes. J. Infect. Dis. 2000, 181(2):442-448.
28. Lerat H., Rumin S., Habersetzer F., Berby F., Trabaud M.A., Trepo C., Inchauspe G. In vivo tropism of hepatitis C virus genomic sequences in hematopoietic cells: influence of viral load, viral genotype, and cell phenotype. Blood 1998, 91(10):3841-3849.
29. Li K., Foy E., Ferreon J.C., Nakamura M., Ferreon A.C., Ikeda M., Ray S.C., Gale M., Lemon S.M. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc. Natl. Acad. Sci. U.S.A. 2005, 102(8):2992-2997.
30. Lin W., Weinberg E.M., Tai A.W., Peng L.F., Brockman M.A., Kim K.A., Kim S.S., Borges C.B., Shao R.X., Chung R.T. HIV increases HCV replication in a TGF-beta1-dependent manner. Gastroenterology 2008, 134(3):803-811.
31. Loo Y.M., Owen D.M., Li K., Erickson A.K., Johnson C.L., Fish P.M., Carney D.S., Wang T., Ishida H., Yoneyama M., Fujita T., Saito T., Lee W.M., Hagedorn C.H., Lau D.T., Weinman S.A., Lemon S.M., Gale M. Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection. Proc. Natl. Acad. Sci. U.S.A. 2006, 103(15):6001-6006.
32. Lu L., Wei L., Peng G., Mu Y., Wu K., Kang L., Yan X., Zhu Y., Wu J. NS3 protein of hepatitis C virus regulates cyclooxygenase-2 expression through multiple signaling pathways. Virology 2008, 371(1):61-70.
33. Maldarelli F., Chen M.Y., Willey R.L., Strebel K. Human immunodeficiency virus type 1 Vpu protein is an oligomeric type I integral membrane protein. J. Virol. 1993, 67(8):5056-5061.
34. Margottin F., Bour S.P., Durand H., Selig L., Benichou S., Richard V., Thomas D., Strebel K., Benarous R. A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif. Mol. Cell 1998, 1(4):565-574.
35. Marzio G., Tyagi M., Gutierrez M.I., Giacca M. HIV-1 tat transactivator recruits p300 and CREB-binding protein histone acetyltransferases to the viral promoter. Proc. Natl. Acad. Sci. U.S.A. 1998, 95(23):13519-13524.
36. Monga H.K., Rodriguez-Barradas M.C., Breaux K., Khattak K., Troisi C.L., Velez M., Yoffe B. Hepatitis C virus infection-related morbidity and mortality among patients with human immunodeficiency virus infection. Clin. Infect. Dis. 2001, 33(2):240-247.
37. Mu Y., Yu Y., Yue X., Musarat I., Gong R., Zhu C., Liu Y., Liu F., Zhu Y., Wu J. The X protein of HBV induces HIV-1 long terminal repeat transcription by enhancing the binding of C/EBPbeta and CREB1/2 regulatory proteins to the long terminal repeat of HIV-1. Virus Res. 2011, 156(1-2):81-90.
38. Mukerjee R., Claudio P.P., Chang J.R., Del Valle L., Sawaya B.E. Transcriptional regulation of HIV-1 gene expression by p53. Cell Cycle 2010, 9(22):4569-4578.
39. Muramatsu S., Ishido S., Fujita T., Itoh M., Hotta H. Nuclear localization of the NS3 protein of hepatitis C virus and factors affecting the localization. J. Virol. 1997, 71(7):4954-4961.
40. Pang P.S., Jankowsky E., Planet P.J., Pyle A.M. The hepatitis C viral NS3 protein is a processive DNA helicase with cofactor enhanced RNA unwinding. EMBO J 2002, 21(5):1168-1176.
41. Paredes A.M., Blight K.J. A genetic interaction between hepatitis C virus NS4B and NS3 is important for RNA replication. J. Virol. 2008, 82(21):10671-10683.
42. Ranjbar S., Boshoff H.I., Mulder A., Siddiqi N., Rubin E.J., Goldfeld A.E. HIV-1 replication is differentially regulated by distinct clinical strains of Mycobacterium tuberculosis. PLoS One 2009, 4(7):e6116.
43. Schagger H. Tricine-SDS-PAGE. Nat. Protoc. 2006, 1(1):16-22.
44. Schubert U., Anton L.C., Bacik I., Cox J.H., Bour S., Bennink J.R., Orlowski M., Strebel K., Yewdell J.W. CD4 glycoprotein degradation induced by human immunodeficiency virus type 1 Vpu protein requires the function of proteasomes and the ubiquitin-conjugating pathway. J. Virol. 1998, 72(3):2280-2288.
45. Schubert U., Henklein P., Boldyreff B., Wingender E., Strebel K., Porstmann T. The human immunodeficiency virus type 1 encoded Vpu protein is phosphorylated by casein kinase-2 (CK-2) at positions Ser52 and Ser56 within a predicted alpha-helix-turn-alpha-helix-motif. J. Mol. Biol. 1994, 236(1):16-25.
46. Suzich J.A., Tamura J.K., Palmer-Hill F., Warrener P., Grakoui A., Rice C.M., Feinstone S.M., Collett M.S. Hepatitis C virus NS3 protein polynucleotide-stimulated nucleoside triphosphatase and comparison with the related pestivirus and flavivirus enzymes. J. Virol. 1993, 67(10):6152-6158.
47. Tai C.L., Chi W.K., Chen D.S., Hwang L.H. The helicase activity associated with hepatitis C virus nonstructural protein 3 (NS3). J. Virol. 1996, 70(12):8477-8484.
48. Tscherne D.M., Jones C.T., Evans M.J., Lindenbach B.D., McKeating J.A., Rice C.M. Time- and temperature-dependent activation of hepatitis C virus for low-pH-triggered entry. J. Virol. 2006, 80(4):1734-1741.
49. Varin A., Decrion A.Z., Sabbah E., Quivy V., Sire J., Van Lint C., Roques B.P., Aggarwal B.B., Herbein G. Synthetic Vpr protein activates activator protein-1, c-Jun N-terminal kinase, and NF-kappaB and stimulates HIV-1 transcription in promonocytic cells and primary macrophages. J. Biol. Chem. 2005, 280(52):42557-42567.
50. Varin A., Manna S.K., Quivy V., Decrion A.Z., Van Lint C., Herbein G., Aggarwal B.B. Exogenous Nef protein activates NF-kappa B, AP-1, and c-Jun N-terminal kinase and stimulates HIV transcription in promonocytic cells. Role in AIDS pathogenesis. J. Biol. Chem. 2003, 278(4):2219-2227.
51. Verma S., Ali A., Arora S., Banerjea A.C. Inhibition of {beta}-TrcP-dependent ubiquitination of p53 by HIV-1 Vpu promotes p53-mediated apoptosis in human T cells. Blood 2011, 117(24):6600-6607.
52. Wang X., Herr R.A., Chua W.J., Lybarger L., Wiertz E.J., Hansen T.H. Ubiquitination of serine, threonine, or lysine residues on the cytoplasmic tail can induce ERAD of MHC-I by viral E3 ligase mK3. J. Cell. Biol. 2007, 177(4):613-624.
53. Wolk B., Sansonno D., Krausslich H.G., Dammacco F., Rice C.M., Blum H.E., Moradpour D. Subcellular localization, stability, and trans-cleavage competence of the hepatitis C virus NS3-NS4A complex expressed in tetracycline-regulated cell lines. J. Virol. 2000, 74(5):2293-2304.
54. Wu X., Ishaq M., Hu J., Guo D. HCV NS3/4A protein activates HIV-1 transcription from its long terminal repeat. Virus Res. 2008, 135(1):155-160.
55. Xiao P., Usami O., Suzuki Y., Ling H., Shimizu N., Hoshino H., Zhuang M., Ashino Y., Gu H., Hattori T. Characterization of a CD4-independent clinical HIV-1 that can efficiently infect human hepatocytes through chemokine (C-X-C motif) receptor 4. AIDS 2008, 22(14):1749-1757.
56. Zhang C., Yang R., Xia X., Qin S., Dai J., Zhang Z., Peng Z., Wei T., Liu H., Pu D., Luo J., Takebe Y., Ben K. High prevalence of HIV-1 and hepatitis C virus coinfection among injection drug users in the southeastern region of Yunnan, China. J. Acquir. Immune Defic. Syndr. (1999) 2002, 29(2):191-196.